×
Atai Life Sciences Long Term Debt 2020-2024 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Atai Life Sciences long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Atai Life Sciences Long Term Debt 2020-2024 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Atai Life Sciences long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$20.6B
Quest Diagnostics (DGX)
$17.4B
DaVita (DVA)
$12.3B
Encompass Health (EHC)
$10.4B
Chemed (CHE)
$8.3B
Elanco Animal Health (ELAN)
$7.2B
RadNet (RDNT)
$5.3B
Option Care Health (OPCH)
$3.9B
Amedisys (AMED)
$3.2B
LifeStance Health (LFST)
$2.9B
Astrana Health (ASTH)
$2.9B
Addus HomeCare (ADUS)
$2.3B
U.S Physical Therapy (USPH)
$1.4B
Pennant (PNTG)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$1.1B
Daxor (DXR)
$45M
MEDIROM Healthcare Technologies (MRM)
$14M
Psychemedics (PMD)
$14M
ATI Physical Therapy (ATIP)
$13M
Ontrak (OTRK)
$8M
IMAC Holdings (BACK)
$1M